title: Pimavanserin as treatment for Parkinson's disease psychosis.
authors.affiliation: Movement Disorder Clinic, University Health Network, Toronto Western Hospital, Toronto, Ontario, Canada M5T 2S8. Electronic address: sfox@uhnresearch.ca.
authors.forename: Susan H
authors.initials: SH
authors.lastname: Fox
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010300:Parkinson Disease / Q000523:psychology*; D010880:Piperidines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy*; D058826:Serotonin 5-HT2 Receptor Agonists / Q000627:therapeutic use*; D014508:Urea / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D010880:Piperidines; D058826:Serotonin 5-HT2 Receptor Agonists; D014508:Urea; C510793:pimavanserin